Skip to main content

Table 3 Plasma levels of MDA and SOD (mean ± SD, n = 6)

From: Combined treatment with bone marrow mesenchymal stem cells and methylprednisolone in paraquat-induced acute lung injury

Group

MDA (nmol/ml)

SOD (U/ml)

 

1d

3d

7d

14d

1d

3d

7d

14d

PQ

4.03 ±0.61 a

4.65 ±0.78 a

5.07 ±0.64 a

 

287.66 ±11.53 a

246.32 ±16.31 a

212.58 ±19.22 a

 

BMSC

3.97 ±0.70 b

4.32 ±0.48 c

4.16 ±0.81 c

3.63±0.56

285.17 ±13.69 b

261.24 ±20.74 c

269.74 ±15.64 c

284.42± 17.56

MP

3.82 ±0.58 d

4.49 ±0.46

4.06 ±0.62

 

294.52 ±10.14 d

265.43 ±15.26

280.15 ±14.58

 

BMSC + MP

3.78 ±0.74

4.20 ±0.29 de

3.79 ±0.51 de

3.31±0.68

292.38 ±9.06

278.66 ±11.84 de

302.37 ±10.11 de

304.15± 10.63

Normal control

3.06 ± 0.24

308.29 ± 18.83

  1. Note: a P < 0.01, vs. normal control group; bP > 0.05, c P < 0.01, vs. PQ group; d P < 0.01, vs. BMSC group; e P < 0.01, vs. MP group.